Regencell Bioscience Holdings Limited
Index- P/E- EPS (ttm)-0.36 Insider Own89.08% Shs Outstand13.36M Perf Week-12.12%
Market Cap387.44M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.74M Perf Month-9.94%
Income-4.60M PEG- EPS next Q- Inst Own0.10% Short Float0.52% Perf Quarter-31.80%
Sales- P/S- EPS this Y-65.80% Inst Trans-47.32% Short Ratio2.24 Perf Half Y-7.91%
Book/sh-0.40 P/B- EPS next Y- ROA- Target Price- Perf Year30.93%
Cash/sh0.01 P/C3874.41 EPS next 5Y- ROE- 52W Range13.25 - 48.29 Perf YTD-8.95%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-39.95% Beta-
Dividend %- Quick Ratio0.00 Sales past 5Y- Gross Margin- 52W Low118.87% ATR1.62
Employees13 Current Ratio0.00 Sales Q/Q- Oper. Margin- RSI (14)39.28 Volatility4.71% 3.92%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.41 Prev Close30.34
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume4.02K Price29.00
Recom- SMA20-8.03% SMA50-12.38% SMA200-6.39% Volume1,638 Change-4.42%
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.